Effects of Saxagliptin on Endothelial Function in Patients With Type 2 Diabetes.

Trial Profile

Effects of Saxagliptin on Endothelial Function in Patients With Type 2 Diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2014

At a glance

  • Drugs Saxagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms ESENDI
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Jul 2012 NCT reports Status as Recruiting and Actual Initiation Date is 1 Oct 2010.
    • 26 May 2012 Actual end date (4 Apr 2012) added as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top